William J Sandborn MD
Professor, Medicine, UC San Diego Sch. of Medicine
Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 800-926-8273
Dr. Sandborn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board-certified gastroenterologist with an expertise in the management of ulcerative colitis and Crohns disease. Currently, I direct the Inflammatory Bowel Disease (IBD) Center at UC San Diego Health. The IBD Center is a large clinical research unit devoted to the conduct of clinical trials in inflammatory bowel disease, where I supervise a multi-investigator team of physicians, research fellows, nurses, and study coordinators.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1990 - 1993
Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 1987 - 1990
Loma Linda University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1988 - 2027
AZ State Medical License 1993 - 2013
MN State Medical License 1990 - 2011
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
Clinical Trials
- Open-Label Adalimumab for Ulcerative Colitis Patients Start of enrollment: 2006 Oct 01
Publications & Presentations
PubMed
- 3 citationsAn International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.Jurij Hanžel, Virginia Solitano, Sudheer Kumar Vuyyuru, Remo Panaccione, Bruce E Sands
Gastroenterology. 2025-11-01 - 3 citationsComparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies.Stefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, William J Sandborn, Silvio Danese
Inflammatory Bowel Diseases. 2025-10-01 - 1 citationsSubcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized cont...Jean-Frederic Colombel, William J Sandborn, Stefan Schreiber, Silvio Danese, Maria Kłopocka
Journal of Crohn's & Colitis. 2025-06-04
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel DiseasesWaseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
- Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis ConceptsParambir S Dulai, William J Sandborn, Brigid S Boland, Derek R Patel, Inflammatory Bowel Diseases
Authored Content
- Progression of Elderly-Onset IBDFebruary 2020
Press Mentions
Organoids Derived from Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s DiseaseSeptember 26th, 2024- Organoids Derived from Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn’s DiseaseSeptember 26th, 2024
- Pivotal Years: Abivax’s Obefazimod Faces Phase III TestDecember 26th, 2022
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
